Henlius (2696 HK): Hurtling Towards a Likely Deal Break

476 Views14 Jan 2025 23:22
LVC’s trading behaviour suggests that it is likely to block the vote. Fosun Pharma has two potential options to secure LVC’s backing. Both have challenges and are, therefore, unlikley.
What is covered in the Full Insight:
  • Introduction to the Deal
  • Significance of the Gross Spread
  • LVC's Role and Voting Intentions
  • Options for Fosun Pharma to Secure Vote
  • Potential Challenges and Conclusion
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
chart-bar
x